Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Simon

Showing results (961-970 of 2,360) with videos related to

Pageof 236
Sort By:
Plos One|April 25, 2015
A systematic review of medication exposure assessment in prospective cohort studies of community dwelling older australiansSusan G Poole, J Simon Bell, Natali Jokanovic, et al.
Experimental and Clinical Cardiology|April 30, 2010
Immunological and histopathological changes in the atrial tissue during and after cardiopulmonary bypassN Alotti, J Sipos, E Roth, et al.
Developmental Neurobiology|August 13, 2009
Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degenerationJ Simon Lunn, Stacey A Sakowski, Bhumsoo Kim, et al.
Orvosi Hetilap|April 6, 2000
[Adult respiratory distress syndrome after open heart surgery]N Alotti, M Varró, K Gombocz, et al.
American Journal of Obstetrics and Gynecology|March 1, 1976
Contraceptive knowledge and practice among undergraduates at a Canadian universityD Munz, S Carson, B Brock, et al.
Journal of Neurobiology|December 25, 2002
Serotonin in the developing stomatogastric system of the lobster, Homarus americanusKathryn S Richards, David J Simon, Stefan R Pulver, et al.
NIDA Research Monograph|January 1, 1986
Purification of kappa-opioid receptor subtype to apparent homogeneity from frog brainA Borsodi, A Khan, J Simon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding-Defective Mutant of ABIN1Sambit K Nanda, Marta Lopez-Pelaez, J Simon C Arthur, et al.
Acta Medica Hungarica|January 1, 1992
The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patientsG Pogatsa, M Z Koltai, G Jermendy, et al.
Biopharmaceutics & Drug Disposition|January 1, 1984
Bioavailability studies with etodolac in dogs and manM Kraml, L Cosyns, D R Hicks, et al.
Pageof 236

Showing results (961-970 of 2,360) with videos related to

Sort By:
Pageof 236
Plos One|April 25, 2015
A systematic review of medication exposure assessment in prospective cohort studies of community dwelling older australiansSusan G Poole, J Simon Bell, Natali Jokanovic, et al.
Experimental and Clinical Cardiology|April 30, 2010
Immunological and histopathological changes in the atrial tissue during and after cardiopulmonary bypassN Alotti, J Sipos, E Roth, et al.
Developmental Neurobiology|August 13, 2009
Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degenerationJ Simon Lunn, Stacey A Sakowski, Bhumsoo Kim, et al.
Orvosi Hetilap|April 6, 2000
[Adult respiratory distress syndrome after open heart surgery]N Alotti, M Varró, K Gombocz, et al.
American Journal of Obstetrics and Gynecology|March 1, 1976
Contraceptive knowledge and practice among undergraduates at a Canadian universityD Munz, S Carson, B Brock, et al.
Journal of Neurobiology|December 25, 2002
Serotonin in the developing stomatogastric system of the lobster, Homarus americanusKathryn S Richards, David J Simon, Stefan R Pulver, et al.
NIDA Research Monograph|January 1, 1986
Purification of kappa-opioid receptor subtype to apparent homogeneity from frog brainA Borsodi, A Khan, J Simon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding-Defective Mutant of ABIN1Sambit K Nanda, Marta Lopez-Pelaez, J Simon C Arthur, et al.
Acta Medica Hungarica|January 1, 1992
The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patientsG Pogatsa, M Z Koltai, G Jermendy, et al.
Biopharmaceutics & Drug Disposition|January 1, 1984
Bioavailability studies with etodolac in dogs and manM Kraml, L Cosyns, D R Hicks, et al.
Pageof 236